BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19307752)

  • 1. LL-37 inhibits serum amyloid A-induced IL-8 production in human neutrophils.
    Lee HY; Kim SD; Shim JW; Lee SY; Yun J; Bae YS
    Exp Mol Med; 2009 May; 41(5):325-33. PubMed ID: 19307752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R.
    He R; Sang H; Ye RD
    Blood; 2003 Feb; 101(4):1572-81. PubMed ID: 12393391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidylglycerol inhibits formyl peptide receptorlike-1-stimulated chemotactic migration and IL-1beta production from human phagocytes.
    Shim JW; Jo SH; Kim SD; Lee HY; Yun J; Bae YS
    Exp Mol Med; 2009 Aug; 41(8):584-91. PubMed ID: 19381066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7.
    Nagaoka I; Tamura H; Hirata M
    J Immunol; 2006 Mar; 176(5):3044-52. PubMed ID: 16493063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.
    De Yang ; Chen Q; Schmidt AP; Anderson GM; Wang JM; Wooters J; Oppenheim JJ; Chertov O
    J Exp Med; 2000 Oct; 192(7):1069-74. PubMed ID: 11015447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells.
    Coffelt SB; Tomchuck SL; Zwezdaryk KJ; Danka ES; Scandurro AB
    Mol Cancer Res; 2009 Jun; 7(6):907-15. PubMed ID: 19491199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cathelicidin antimicrobial peptide LL-37 promotes lymphangiogenesis in lymphatic endothelial cells through the ERK and Akt signaling pathways.
    Yanagisawa T; Ishii M; Takahashi M; Fujishima K; Nishimura M
    Mol Biol Rep; 2020 Sep; 47(9):6841-6854. PubMed ID: 32886325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1.
    Björkman L; Karlsson J; Karlsson A; Rabiet MJ; Boulay F; Fu H; Bylund J; Dahlgren C
    J Leukoc Biol; 2008 Feb; 83(2):245-53. PubMed ID: 17984291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1.
    Christenson K; Björkman L; Tängemo C; Bylund J
    J Leukoc Biol; 2008 Jan; 83(1):139-48. PubMed ID: 17962368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors.
    Tjabringa GS; Ninaber DK; Drijfhout JW; Rabe KF; Hiemstra PS
    Int Arch Allergy Immunol; 2006; 140(2):103-12. PubMed ID: 16557028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes.
    Lee HY; Kim SD; Shim JW; Lee SY; Lee H; Cho KH; Yun J; Bae YS
    J Immunol; 2008 Sep; 181(6):4332-9. PubMed ID: 18768891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells.
    Lee HY; Kim MK; Park KS; Bae YH; Yun J; Park JI; Kwak JY; Bae YS
    Biochem Biophys Res Commun; 2005 May; 330(3):989-98. PubMed ID: 15809093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1.
    Wan M; Godson C; Guiry PJ; Agerberth B; Haeggström JZ
    FASEB J; 2011 May; 25(5):1697-705. PubMed ID: 21307335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential activation of formyl peptide receptor-like 1 by peptide ligands.
    Bae YS; Yi HJ; Lee HY; Jo EJ; Kim JI; Lee TG; Ye RD; Kwak JY; Ryu SH
    J Immunol; 2003 Dec; 171(12):6807-13. PubMed ID: 14662886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation in the Presence of Influenza Virus: Functional and Structural Analysis.
    Tripathi S; Wang G; White M; Rynkiewicz M; Seaton B; Hartshorn K
    PLoS One; 2015; 10(8):e0133454. PubMed ID: 26308522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host Defense Peptide LL-37-Mediated Chemoattractant Properties, but Not Anti-Inflammatory Cytokine IL-1RA Production, Is Selectively Controlled by Cdc42 Rho GTPase
    Hemshekhar M; Choi KG; Mookherjee N
    Front Immunol; 2018; 9():1871. PubMed ID: 30158931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant.
    Kurosaka K; Chen Q; Yarovinsky F; Oppenheim JJ; Yang D
    J Immunol; 2005 May; 174(10):6257-65. PubMed ID: 15879124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FPRL1-mediated induction of superoxide in LL-37-stimulated IMR90 human fibroblast.
    Iaccio A; Cattaneo F; Mauro M; Ammendola R
    Arch Biochem Biophys; 2009 Jan; 481(1):94-100. PubMed ID: 18996352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pertussis toxin sensitive G-protein-independent pathway is involved in serum amyloid A-induced formyl peptide receptor 2-mediated CCL2 production.
    Lee HY; Kim SD; Shim JW; Kim HJ; Yun J; Baek SH; Kim K; Bae YS
    Exp Mol Med; 2010 Apr; 42(4):302-9. PubMed ID: 20177146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2.
    Chen M; Zhou H; Cheng N; Qian F; Ye RD
    Immunobiology; 2014 Dec; 219(12):916-23. PubMed ID: 25154907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.